The new MD brings over 23 years of global biopharma leadership experience, looking to help MSD continue to strengthen its partnerships with stakeholders to support efforts related to prevention, screening, innovative treatment, and healthcare digitalization in Hungary.
The company is set to continue its investment in clinical research and utilize real-world evidence to further optimize patient outcomes, MSD Hungary tells the Budapest Business Journal.
“I look forward to making meaningful contributions by continuing MSD´s commitment to Hungary, working with our partners, our customers, and our employees to transform the lives of patients here, through bringing our groundbreaking healthcare innovations and solutions to all people in need,” Sean R. Smith said.
Producing journalism that is worthy of the name is a costly business. For over 30 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.
